Cite
HARVARD Citation
Wiley, F. (2021). Dalpiciclib + Fulvestrant in Relapsed or Progressed HR+/HER2- Breast Cancer. Oncology times. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wiley, F. (2021). Dalpiciclib + Fulvestrant in Relapsed or Progressed HR+/HER2- Breast Cancer. Oncology times. p. . [Online].